Minimal residual disease evaluation in autologous stem cell transplantation recipients with multiple myeloma
Ritu Gupta1, Lalit Kumar2, Meetu Dahiya1
1a Laboratory Oncology Unit, Dr. B.R.A.IRCH, All India Institute of Medical Sciences (AIIMS) , New Delhi , India.
Leukemia & Lymphoma
|September 24, 2016
Abstract
No abstract available in PubMed .
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.8K
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.2K
